Free Trial
The Market Does Not Wait. MarketBeat All Access Alerts for $149
Get the Alerts
Claim MarketBeat All Access Sale Promotion

Kenvue (KVUE) Projected to Release Earnings on Friday

Kenvue logo with Consumer Staples background
Image from MarketBeat Media, LLC.

Key Points

Kenvue (NYSE:KVUE - Get Free Report) will likely be announcing its Q3 2026 results before the market opens on Friday, October 30th. Analysts expect Kenvue to post earnings of $0.2915 per share and revenue of $3.86 billion for the quarter. Individuals may review the information on the company's upcoming Q3 2026 earnings summary page for the latest details on the call scheduled for Friday, October 30, 2026 at 9:30 AM ET.

Kenvue (NYSE:KVUE - Get Free Report) last released its quarterly earnings results on Thursday, August 6th. The company reported $0.31 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.32 by ($0.01). Kenvue had a return on equity of 21.22% and a net margin of 10.76%. The company had revenue of $3.96 billion for the quarter, compared to the consensus estimate of $3.97 billion. During the same quarter last year, the company posted $0.29 EPS. The business's revenue was up 3.0% compared to the same quarter last year. On average, analysts expect Kenvue to post $1.14 EPS for the current fiscal year and $1.23 EPS for the next fiscal year.

Kenvue Stock Up 4.4%

Shares of KVUE stock opened at $19.89 on Friday. The stock's 50 day simple moving average is $18.34 and its 200 day simple moving average is $18.26. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.71 and a current ratio of 1.01. Kenvue has a twelve month low of $14.02 and a twelve month high of $20.13. The company has a market capitalization of $38.19 billion, a price-to-earnings ratio of 22.86, a PEG ratio of 1.74 and a beta of 0.48.

Kenvue Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, October 2nd. Shareholders of record on Monday, September 21st were given a dividend of $0.21 per share. The ex-dividend date of this dividend was Monday, September 21st. This represents a $0.84 dividend on an annualized basis and a yield of 4.2%. Kenvue's dividend payout ratio is presently 96.55%.

Analysts Set New Price Targets

KVUE has been the subject of a number of recent analyst reports. Barclays upped their target price on Kenvue from $18.00 to $19.00 and gave the stock an "equal weight" rating in a research report on Tuesday, July 21st. UBS Group dropped their price target on shares of Kenvue from $20.00 to $19.00 and set a "neutral" rating on the stock in a research report on Tuesday, August 11th. Weiss Ratings restated a "hold (c)" rating on shares of Kenvue in a research note on Friday, September 11th. Zacks Research cut shares of Kenvue from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, July 7th. Finally, Wall Street Zen downgraded shares of Kenvue from a "buy" rating to a "hold" rating in a report on Saturday, August 8th. Ten investment analysts have rated the stock with a Hold rating. Based on data from MarketBeat, Kenvue presently has an average rating of "Hold" and a consensus target price of $18.43.

View Our Latest Research Report on KVUE

About Kenvue

(Get Free Report)

Kenvue Inc is a consumer health company that develops, markets and sells products designed to support everyday health and personal care. Its portfolio spans over-the-counter medicines, skin health and beauty, and essential health products, serving consumers through retail, e-commerce and other distribution channels.

The company's brands include Tylenol, Motrin, Zyrtec and Benadryl in self-care; Neutrogena, Aveeno and Clean & Clear in skin health and beauty; and Listerine, Johnson's and OGX in oral care, baby care and hair care.

Read More

Earnings History for Kenvue (NYSE:KVUE)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Kenvue Right Now?

Before you consider Kenvue, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kenvue wasn't on the list.

While Kenvue currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Best Space Stocks to Own in 2026 Cover

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines